TVP23C-CDRT4

Across TCGA pan-cancer cohorts, TVP23C-CDRT4 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated TVP23C-CDRT4 data layer compared with 25 for mass-spec protein.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher TVP23C-CDRT4 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated TVP23C-CDRT4 expression acts as an unfavorable survival marker.

LUAD and PRAD are the cancer types where TVP23C-CDRT4 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Median	All	0.098	0.791	<.001	18	view →
PRAD	DFS	Median	All	0.085	0.774	<.001	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

TVP23C-CDRT4–LUAD (DFS)

Open the LUAD breakdown →